Literature DB >> 1722861

Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency.

H J ten Brink1, R J Wanders, F Stellaard, R B Schutgens, C Jakobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1722861     DOI： 10.1007/bf01811699

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  A bifunctional protein with deficient enzymic activity: identification of a new peroxisomal disorder using novel methods to measure the peroxisomal beta-oxidation enzyme activities.

Authors:  R J Wanders; C W van Roermund; A Schelen; R B Schutgens; J M Tager; J B Stephenson; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Studies on the alpha oxidation of phytanic acid by rat liver mitochondria.

Authors:  S C Tsai; J Avigan; D Steinberg
Journal:  J Biol Chem       Date:  1969-05-25       Impact factor: 5.157

3.  Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.

Authors:  A Poulos; P Sharp; A J Fellenberg; D W Johnson
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183
  3 in total
  6 in total

1.  Bone dysplasia associated with phytanic acid accumulation and deficient plasmalogen synthesis: a peroxisomal entity amenable to plasmapheresis.

Authors:  J A Smeitink; F A Beemer; M Espeel; R A Donckerwolcke; C Jakobs; R J Wanders; R B Schutgens; F Roels; M Duran; L Dorland
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder.

Authors:  Y Suzuki; L L Jiang; M Souri; S Miyazawa; S Fukuda; Z Zhang; M Une; N Shimozawa; N Kondo; T Orii; T Hashimoto
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

3.  Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome.

Authors:  F Mochel; A-G Grébille; A Benachi; J Martinovic; F Razavi; D Rabier; I Simon; N Boddaert; F Brunelle; P Sonigo
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

4.  Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase.

Authors:  H J ten Brink; B T Poll-The; J M Saudubray; R J Wanders; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.

Authors:  B C Paton; P C Sharp; D I Crane; A Poulos
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

6.  Comparison of fatty acid alpha-oxidation by rat hepatocytes and by liver microsomes fortified with NADPH, Fe3+ and phosphate.

Authors:  S Huang; P P Van Veldhoven; S Asselberghs; H J Eyssen; E de Hoffmann; G P Mannaerts
Journal:  Lipids       Date:  1994-10       Impact factor: 1.880
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.